Rho Offers Advice for Leveraging Opportunities Afforded by the FDA’s Priority Review Voucher System in Free Webinar
WHAT:
Rho, a full-service contract research organization (CRO), will walk through the how’s and why’s of the FDA’s Priority Review Voucher program during a free webinar. This regulatory program can simultaneously benefit both blockbuster drugs and rare or neglected diseases.
In this webinar, Rho experts Kelly Roney, senior research scientist, Sheila Bello-Irizarry, integrated product development associate, and Devin Rosenthal, research scientist, will discuss why the program was created, who can benefit from the program, changes over the past nine years, challenges and limitations, and the future of the program.
WHO:
Kelly Roney, senior research scientist, Rho
Sheila Bello-Irizarry, integrated product development associate, Rho
Devin Rosenthal, research scientist, Rho
WHEN:
Thursday, December 8, 2016
1 p.m. ET
Duration: 60 minutes
Webinar registration: http://bit.ly/2gPjec3
DETAILS:
For media inquiries, please contact Jen Caro at Largemouth Communications, (919) 459-6456, jennifer@largemouthpr.com .
ABOUT:
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 32 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter .
Rho, a full-service contract research organization (CRO), will walk through the how’s and why’s of the FDA’s Priority Review Voucher program during a free webinar. This regulatory program can simultaneously benefit both blockbuster drugs and rare or neglected diseases.
In this webinar, Rho experts Kelly Roney, senior research scientist, Sheila Bello-Irizarry, integrated product development associate, and Devin Rosenthal, research scientist, will discuss why the program was created, who can benefit from the program, changes over the past nine years, challenges and limitations, and the future of the program.
WHO:
Kelly Roney, senior research scientist, Rho
Sheila Bello-Irizarry, integrated product development associate, Rho
Devin Rosenthal, research scientist, Rho
WHEN:
Thursday, December 8, 2016
1 p.m. ET
Duration: 60 minutes
Webinar registration: http://bit.ly/2gPjec3
DETAILS:
For media inquiries, please contact Jen Caro at Largemouth Communications, (919) 459-6456, jennifer@largemouthpr.com
ABOUT:
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 32 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com